CLASS III Drug recall · Reported 22 Sep 2021 · FDA Enforcement Report

Candesartan Cilexetil Tablets, USP 16 mg recalled by Viatris

Viatris is recalling Candesartan Cilexetil Tablets, USP 16 mg, distributed nationwide in the US. The recall was initiated on 13 Sep 2021 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # 3107334, exp. date October 2021
NDC0378-3224, 0378-3225, 0378-3231, 0378-3232
UPC0303783232935, 0303783225937, 0303783224930
Quantity recalled21,094

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0798-2021
FDA event ID
88609
Recalling firm
Viatris, Morgantown, WV
Manufacturer
Mylan Pharmaceuticals Inc.
Classification
Class III
Status
Terminated
Recall initiated
13 Sep 2021
FDA classified
14 Sep 2021
Reported
22 Sep 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

13 Sep 2021Recall initiated by company
14 Sep 2021Classified by FDA+1 day
22 Sep 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications; out of specification for Related Compound

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93

Where it was distributed

Product was distributed nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications; out of specification for Related Compound

Which lots are affected?

Lot # 3107334, exp. date October 2021

Where was it sold?

Product was distributed nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Viatris

All 26

Other Candesartan Cilexetil recalls

All 11